Health care companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Roivant Sciences leads the 154 health care companies ranked by P/S ratio, at 3397, ahead of Dianthus Therapeutics (2323) and CG Oncology (1769). Figures as of 19 Nov 2026, 14:03 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 154
- First
- Roivant Sciences3397
- Median
- 4.3
- Combined market value
- SEK 92.2T
- Countries
- 14
- Not ranked
- 16no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/S ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Roivant SciencesROIV · Health Care | 3397 | SEK 284.5B | SEK 392.61 | 0.05% up | 91% up | ||
| 2 | Dianthus TherapeuticsDNTH · Health Care | 2323 | SEK 47.9B | SEK 851.31 | 3.45% down | 108% up | ||
| 3 | CG OncologyCGON · Health Care | 1769 | SEK 72.4B | SEK 810.96 | 1.34% up | 97% up | ||
| 4 | CRISPR TherapeuticsCRSP · Health Care | 1111 | SEK 39.5B | SEK 407.41 | 0.10% up | 18% down | ||
| 5 | Kymera TherapeuticsKYMR · Health Care | 264 | SEK 104.8B | SEK 1,227.90 | 0.32% down | 87% up | ||
| 6 | Protagonist TherapeuticsPTGX · Health Care | 180 | SEK 84.1B | SEK 1,289.03 | 2.00% up | 51% up | ||
| 7 | CytokineticsCYTK · Health Care | 81.2 | SEK 72.5B | SEK 520.23 | 0.64% down | 19% down | ||
| 8 | ImmunityBioIBRX · Health Care | 62.9 | SEK 72.3B | SEK 67.92 | 7.03% up | 232% up | ||
| 9 | Rhythm PharmaceuticalsRYTM · Health Care | 43.5 | SEK 83.7B | SEK 1,206.71 | 2.08% up | 18% up | ||
| 10 | InsmedINSM · Health Care | 43.3 | SEK 266.4B | SEK 1,214.42 | 1.69% down | 40% down | ||
| 11 | ModernaMRNA · Health Care | 41.0 | SEK 807.2B | SEK 1,994.87 | 4.84% down | 780% up | ||
| 12 | GRAILGRAL · Health Care | 31.2 | SEK 46.5B | SEK 1,034.99 | 3.57% down | 19% up | ||
| 13 | BridgeBio PharmaBBIO · Health Care | 30.3 | SEK 154B | SEK 790.79 | 1.58% up | 21% up | ||
| 14 | WatersWAT · Health Care | 28.9 | SEK 928.6B | SEK 4,724.88 | 3.63% up | 23% up | ||
| 15 | GlaukosGKOS · Health Care | 27.2 | SEK 139.9B | SEK 2,362.74 | 4.18% down | 145% up | ||
| 16 | Krystal BiotechKRYS · Health Care | 24.0 | SEK 94.7B | SEK 3,196.62 | 5.62% up | 54% up | ||
| 17 | HeartflowHTFL · Health Care | 22.9 | SEK 40.9B | SEK 465.19 | 2.51% down | 66% up | ||
| 18 | Ligand PharmaceuticalsLGND · Health Care | 22.3 | SEK 60.6B | SEK 3,028.04 | 1.67% up | 50% up | ||
| 19 | Ascendis PharmaASND · Health Care | 22.2 | SEK 179.8B | SEK 2,740.35 | 0.32% down | 29% up | ||
| 20 | Twist BioscienceTWST · Health Care | 21.1 | SEK 80.4B | SEK 1,179.45 | 3.88% up | 346% up | ||
| 21 | Guardant HealthGH · Health Care | 20.0 | SEK 199B | SEK 1,471.29 | 1.30% up | 45% up | ||
| 22 | Eli LillyLLY · Health Care | 18.9 | SEK 12.49T | SEK 14,017.01 | 2.32% down | 33% up | ||
| 23 | NateraNTRA · Health Care | 18.2 | SEK 425.5B | SEK 2,934.68 | 0.71% up | 28% up | ||
| 24 | Adaptive BiotechnologiesADPT · Health Care | 16.6 | SEK 46.7B | SEK 288.50 | 0.11% down | 74% up | ||
| 25 | Royalty PharmaRPRX · Health Care | 16.6 | SEK 400.3B | SEK 696.11 | 0.01% down | 79% up | ||
| 26 | TG TherapeuticsTGTX · Health Care | 16.2 | SEK 101.3B | SEK 670.26 | 5.44% up | 117% up | ||
| 27 | RepligenRGEN · Health Care | 15.0 | SEK 111.9B | SEK 1,750.36 | 6.47% up | 12% up | ||
| 28 | Intuitive SurgicalISRG · Health Care | 14.5 | SEK 1.48T | SEK 4,267.19 | 2.23% down | 24% down | ||
| 29 | BillionToOneBLLN · Health Care | 14.3 | SEK 44.3B | SEK 927.95 | 6.11% down | 4% down | ||
| 30 | argenxARGX · Health Care | 14.3 | SEK 600B | SEK 9,541.50 | 0.66% down | 2% up | ||
| 31 | IDEXX LaboratoriesIDXX · Health Care | 12.8 | SEK 557.8B | SEK 7,080.43 | 1.19% up | 1% up | ||
| 32 | 10x GenomicsTXG · Health Care | 11.7 | SEK 76.1B | SEK 578.52 | 1.37% up | 247% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | 11.6 | SEK 61.2B | SEK 937.58 | 0.59% up | 34% up | ||
| 34 | Vertex PharmaceuticalsVRTX · Health Care | 11.3 | SEK 1.38T | SEK 5,438.02 | 0.42% up | 27% up | ||
| 35 | Axsome TherapeuticsAXSM · Health Care | 11.0 | SEK 71.4B | SEK 1,358.36 | 1.43% down | 6% down | ||
| 36 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.0 | SEK 75.7B | SEK 963.53 | 0.06% down | 129% up | ||
| 37 | Edwards LifesciencesEW · Health Care | 10.0 | SEK 613.4B | SEK 1,066.72 | 0.19% down | 25% up | ||
| 38 | Travere TherapeuticsTVTX · Health Care | 9.8 | SEK 48.9B | SEK 509.29 | 1.68% down | 45% up | ||
| 39 | Corcept TherapeuticsCORT · Health Care | 9.7 | SEK 75.2B | SEK 687.19 | 3.25% down | 10% down | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | SEK 93.7B | SEK 4,035.36 | 5.67% down | 27% down | ||
| 41 | Bio-TechneTECH · Health Care | 9.4 | SEK 115.8B | SEK 737.47 | 0.17% up | 24% up | ||
| 42 | West Pharmaceutical ServicesWST · Health Care | 9.2 | SEK 285.3B | SEK 4,095.57 | 2.44% down | 57% up | ||
| 43 | PenumbraPEN · Health Care | 9.0 | SEK 128.1B | SEK 3,249.94 | 0.47% up | 15% up | ||
| 44 | BeOne MedicinesONC · Health Care | 8.6 | SEK 467.3B | SEK 4,091.31 | 2.34% down | 16% up | ||
| 45 | Mettler-Toledo InternationalMTD · Health Care | 8.6 | SEK 350.3B | SEK 17,610.69 | 1.42% up | 24% up | ||
| 46 | GenmabGMAB · Health Care | 8.4 | SEK 318.6B | SEK 516.69 | 1.91% down | 70% up | ||
| 47 | AbbVieABBV · Health Care | 8.3 | SEK 5.12T | SEK 2,899.30 | 2.33% down | 25% up | ||
| 48 | Halozyme TherapeuticsHALO · Health Care | 7.8 | SEK 110.7B | SEK 971.13 | 0.18% down | 39% up | ||
| 49 | United TherapeuticsUTHR · Health Care | 7.7 | SEK 249.3B | SEK 5,852.52 | 1.16% down | 22% up | ||
| 50 | Arrowhead PharmaceuticalsARWR · Health Care | 7.3 | SEK 61.8B | SEK 437.01 | 0.28% up | 13% up | ||
| 51 | IlluminaILMN · Health Care | 7.3 | SEK 321.9B | SEK 2,128.88 | 3.65% up | 76% up | ||
| 52 | Agilent TechnologiesA · Health Care | 7.2 | SEK 506.9B | SEK 1,797.60 | 2.97% up | 22% up | ||
| 53 | ExelixisEXEL · Health Care | 7.2 | SEK 168.9B | SEK 692.26 | 0.31% down | 63% up | ||
| 54 | Medpace HoldingsMEDP · Health Care | 7.2 | SEK 183.4B | SEK 6,557.35 | 0.95% down | 10% up | ||
| 55 | Gilead SciencesGILD · Health Care | 7.1 | SEK 2.12T | SEK 1,712.96 | 0.75% down | 35% up | ||
| 56 | Johnson & JohnsonJNJ · Health Care | 7.0 | SEK 6.65T | SEK 2,764.37 | 2.15% down | 34% up | ||
| 57 | Caris Life SciencesCAI · Health Care | 6.9 | SEK 56.7B | SEK 197.67 | 2.21% down | 19% down | ||
| 58 | Regeneron PharmaceuticalsREGN · Health Care | 6.8 | SEK 991.5B | SEK 9,584.88 | 1.28% down | 28% up | ||
| 59 | DexComDXCM · Health Care | 6.6 | SEK 312B | SEK 836.51 | 0.59% up | 41% up | ||
| 60 | DanaherDHR · Health Care | 6.5 | SEK 1.63T | SEK 2,317.13 | 1.24% up | 3% up | ||
| 61 | AmgenAMGN · Health Care | 6.5 | SEK 2.43T | SEK 4,499.74 | 3.07% down | 32% up | ||
| 62 | BioNTechBNTX · Health Care | 6.5 | SEK 209.3B | SEK 844.01 | 1.89% down | 14% down | ||
| 63 | HealthEquityHQY · Health Care | 6.1 | SEK 81.6B | SEK 986.44 | 4.45% down | 3% down | ||
| 64 | ResMedRMD · Health Care | 6.0 | SEK 345.9B | SEK 2,459.35 | 2.00% up | 1% down | ||
| 65 | RevvityRVTY · Health Care | 6.0 | SEK 172.5B | SEK 1,545.19 | 3.14% up | 62% up | ||
| 66 | Neurocrine BiosciencesNBIX · Health Care | 5.8 | SEK 167.1B | SEK 1,650.92 | 1.84% down | 17% up | ||
| 67 | Thermo Fisher ScientificTMO · Health Care | 5.8 | SEK 2.6T | SEK 7,022.34 | 0.87% up | 21% up | ||
| 68 | Alnylam PharmaceuticalsALNY · Health Care | 5.4 | SEK 202.8B | SEK 1,514.48 | 4.54% down | 66% down | ||
| 69 | NovartisNVS · Health Care | 5.4 | SEK 2.97T | SEK 1,573.37 | 2.46% down | 25% up | ||
| 70 | AlkermesALKS · Health Care | 5.3 | SEK 79.8B | SEK 474.92 | 3.08% up | 66% up | ||
| 71 | Merck & CoMRK · Health Care | 5.2 | SEK 3.44T | SEK 1,396.68 | 3.90% down | 45% up | ||
| 72 | QiagenQGEN · Health Care | 4.9 | SEK 103.7B | SEK 502.39 | 0.38% down | 9% up | ||
| 73 | Ionis PharmaceuticalsIONS · Health Care | 4.8 | SEK 46.2B | SEK 277.65 | 1.59% up | 63% down | ||
| 74 | StrykerSYK · Health Care | 4.8 | SEK 1.23T | SEK 3,225.10 | 0.19% up | 12% down | ||
| 75 | AstraZenecaAZN · Health Care | 4.7 | SEK 2.81T | SEK 1,812.10 | 1.93% down | 1% up | ||
| 76 | IncyteINCY · Health Care | 4.7 | SEK 243.4B | SEK 1,194.14 | 1.08% down | 16% up | ||
| 77 | Lantheus HoldingsLNTH · Health Care | 4.3 | SEK 67.6B | SEK 1,033.98 | 0.20% up | 90% up | ||
| 78 | STERISSTE · Health Care | 4.2 | SEK 255.5B | SEK 2,631.27 | 0.84% up | 1% up | ||
| 79 | HaemoneticsHAE · Health Care | 4.2 | SEK 56.7B | SEK 1,245.44 | 1.60% up | 64% up | ||
| 80 | Abbott LaboratoriesABT · Health Care | 4.1 | SEK 1.83T | SEK 1,059.12 | 0.22% down | 16% down | ||
| 81 | Charles River Laboratories InternationalCRL · Health Care | 4.0 | SEK 161.9B | SEK 3,378.17 | 0.33% up | 106% up | ||
| 82 | Bio-Rad LaboratoriesBIO · Health Care | 3.9 | SEK 100.9B | SEK 3,752.43 | 3.34% up | 22% up | ||
| 83 | Novo NordiskNVO · Health Care | 3.8 | SEK 1.76T | SEK 399.70 | 3.12% down | 17% down | ||
| 84 | BiogenBIIB · Health Care | 3.8 | SEK 376.7B | SEK 2,548.56 | 0.25% up | 49% up | ||
| 85 | LivaNovaLIVN · Health Care | 3.8 | SEK 52.8B | SEK 958.36 | 2.85% up | 77% up | ||
| 86 | Jazz PharmaceuticalsJAZZ · Health Care | 3.7 | SEK 161.2B | SEK 2,511.66 | 2.93% up | 41% up | ||
| 87 | BioMarin PharmaceuticalBMRN · Health Care | 3.7 | SEK 120.6B | SEK 622.72 | 4.99% up | 17% up | ||
| 88 | LifeStance Health GroupLFST · Health Care | 3.7 | SEK 53.1B | SEK 139.59 | 2.82% down | 123% up | ||
| 89 | ZoetisZTS · Health Care | 3.7 | SEK 352.4B | SEK 867.43 | 2.50% up | 26% down | ||
| 90 | MSA SafetyMSA · Health Care | 3.6 | SEK 69.3B | SEK 1,798.82 | 2.67% up | 16% up | ||
| 91 | InsuletPODD · Health Care | 3.6 | SEK 98.4B | SEK 1,418.98 | 3.69% down | 55% down | ||
| 92 | MedtronicMDT · Health Care | 3.5 | SEK 1.31T | SEK 1,021.00 | 1.56% down | 1% up | ||
| 93 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.5 | SEK 126.6B | SEK 151.85 | 1.28% up | 8% up | ||
| 94 | AlconALC · Health Care | 3.5 | SEK 366.5B | SEK 762.91 | 1.55% up | 0% up | ||
| 95 | Merit Medical SystemsMMSI · Health Care | 3.4 | SEK 52.2B | SEK 871.08 | 1.70% up | 1% up | ||
| 96 | TeleflexTFX · Health Care | 3.3 | SEK 66.7B | SEK 1,681.23 | 3.95% up | 58% up | ||
| 97 | Globus MedicalGMED · Health Care | 3.2 | SEK 94.7B | SEK 714.97 | 0.77% up | 14% down | ||
| 98 | Boston ScientificBSX · Health Care | 3.2 | SEK 641.2B | SEK 442.38 | 1.42% up | 55% down | ||
| 99 | Legend BiotechLEGN · Health Care | 3.1 | SEK 32B | SEK 164.73 | 0.87% up | 41% down | ||
| 100 | PTC TherapeuticsPTCT · Health Care | 2.9 | SEK 51B | SEK 610.55 | 0.22% down | 21% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1371 SEK). 16 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies rank first by P/S ratio?
Roivant Sciences (3397), Dianthus Therapeutics (2323) and CG Oncology (1769) are the top three of the 154 health care companies ranked by P/S ratio as of 19 Nov 2026, 14:03 UTC.
How many health care companies are in this ranking?
154 are ranked by P/S ratio. 16 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 154 health care companies ranked by P/S ratio have a combined market value of SEK 92.2T as of 19 Nov 2026, 14:03 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.